Summary

• Alignment Healthcare (ALHC) shows strong technical indicators with 100% buy signals, a 217.60+ Weighted Alpha, and a 263.09% gain in the last year.

• The stock is above its 20, 50, and 100-day moving averages, with a recent price of $17.61 and a 50-day average of $14.81.

• ALHC's fundamentals are robust, with a market cap of $3.33 billion, expected revenue growth of 38.69% this year, and earnings projected to increase 41.93%.

• Analysts are bullish with 8 strong buys, and MorningStar rates it 7% undervalued; however, the stock is volatile and speculative.

The Chart of the Day belongs to the senior healthcare company Alignment Healthcare (ALHC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 3/3 the stock gained 13.47%.

ALHC Price vs Daily Moving Averages:

ALHC (Barchart)

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. The company was founded in 2013 and is based in Orange, California. 

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart Technical Indicators:

• 100% technical buy signals
• 217.60+ Weighted Alpha
• 263.09 gain in the last year
• 1.49 - 60 month Beta
• Trend Seeker buy signal
• Above its 20, 50 and 100 day moving averages
• 8 new highs and up 33.61% in the last month
• Relative Strength Index 72.74%
• Technical support level at $17.12
• Recently traded at $17.61 with 50 day moving average of $14.81

Fundamental Factors:

• Market Cap $3.33 billion
• Revenue expected to grow 38.69% this year and another 25.28% next year
• Earnings estimated to increase 41.93% this year and an additional 120.95% next year

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts issued 8 strong buy, 1 buy, 3 hold  and 1 sell opinion  on the stock with price targets between $9 and $21
• CFRAs MarketScope give the stock a strong buy rating
• MorningStar thinks the stock is 7% under valued
• 1,290 investors monitor the stock on Seeking Alpha

Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance and reevaluate your stop losses at least on a weekly basis.

On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More By This Author:

Banco De Chile - Great South Of The Border Investment
Beware Of FOMO
Gilead Sciences - Leader In HIV Medicines